AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

EXAGEN INC. Director's Dealing 2020

Apr 15, 2020

33644_dirs_2020-04-15_771c9637-b30c-481b-bee1-6583922c80b4.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: EXAGEN INC. (XGN)
CIK: 0001274737
Period of Report: 2020-04-13

Reporting Person: PALLARES EBETUEL (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-04-13	Common Stock	J	144033	$0.00	Disposed	0	Indirect
2020-04-13	Common Stock	J	1185	$0.00	Acquired	1185	Direct

Footnotes

F1: PCM/Exagen, L.P. (PCM) distributed 144,033 shares of Common Stock of the Issuer to its limited partners on a pro rata basis, for no consideration.

F2: The shares reported on this form are held of record by PCM/Exgen, L.P. Ebetuel Palleres is co-manager of PCM. As a result, each of PCM and Dr. Palleres may be deemed to share beneficial ownership of the shares held of record by PCM.

F3: Dr. Pallares received shares distributed by PCM on a pro rata basis for no consideration to its limited partners.